Search results
Novavax seeks FDA approval for updated Covid-19 vaccine
Pharmaceutical Technology via Yahoo Finance· 4 days agoNovavax has submitted an application to the US Food and Drug Administration (FDA) seeking approval...
Novavax seeks FDA nod for updated COVID-19 vaccine By Investing.com
Investing.com· 7 days agoNovavax , Inc. (NASDAQ: NASDAQ:NVAX) has announced its submission for an amended Emergency Use...
Novavax’s South African Phase IIb COVID-19 vaccine trial likely to reveal results within next...
Pharmaceutical Technology via Yahoo Finance· 3 days agoSouth Africa’s existing regulatory, consent and ethics frameworks around HIV vaccine trial investigations helped with regards to quick initiation and straightforward progress of COVID-19 vaccine trials in the country, the source said.
Jim Cramer Says He's 'Going To Have To Wait' On SoFi, But Recommends This 'Great Little Industrial...
Benzinga· 4 days agoOn CNBC's “Mad Money Lightning Round,” Jim Cramer said he still can't recommend Twilio TWLO. On June...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 21 hours agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...
FDA asks COVID vaccine makers to target KP.2 strain, if feasible, for next shot
Reuters via Yahoo News· 7 days agoThe Food and Drug Administration's change in recommendation, in an update dated Thursday, comes even...
FDA modifies strain recommendation for fall COVID vaccine amid variant shifts, uptick in cases
Center for Infectious Disease Research and Policy· 7 days agoOn June 5, the FDA's vaccine advisory group recommended a switch to the JN.1 variant, though it held...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
Fox News· 6 days agoThe U.S. Food and Drug Administration (FDA) has recommended that COVID vaccine manufacturers update...
Novavax applies for FDA nod for its updated COVID vaccine
Center for Infectious Disease Research and Policy· 4 days agoThe company said it will have the vaccine ready to distribute in mid July as prefilled syringes, pending approval and recommendations.
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 20 hours agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...